RxDB
ICD-10-CM Codes Browse (Tabular) Diagnostic External Drug Neoplasm

T45.8X5S – Adverse effect of other primarily systemic and hematological agents, sequela

Overview

Coding Notes

Active
Billable, valid for HIPAA-covered transactions

GEM Conversion to ICD-9 CM

Fs: 10111 – Late effect of adverse effect of drug, medicinal or biological substance
Fs: 10121 – Late effect of adverse effect of drug, medicinal or biological substance
Fs: 10112 – Oral bisphosphonates
Fs: 10112 – Intravenous bisphosphonates
Fs: 10112 – Other systemic agents, not elsewhere classified, causing adverse effects in therapeutic use
Fs: 10122 – Other agents affecting blood constituents causing adverse effects in therapeutic use

MDC / MS-DRG Reference

OTHER INJURY, POISONING AND TOXIC EFFECT DIAGNOSES WITH MCC
OTHER INJURY, POISONING AND TOXIC EFFECT DIAGNOSES WITHOUT MCC

Sibling Codes

Adverse effect of other primarily systemic and hematological agents, initial encounter
Adverse effect of other primarily systemic and hematological agents, subsequent encounter

Parent Sibling Codes

Poisoning by other primarily systemic and hematological agents, accidental (unintentional)
Poisoning by other primarily systemic and hematological agents, intentional self-harm
Poisoning by other primarily systemic and hematological agents, assault
Poisoning by other primarily systemic and hematological agents, undetermined
Adverse effect of other primarily systemic and hematological agents
Underdosing of other primarily systemic and hematological agents

Codes with Same Suffix

Adverse effect of other systemic antibiotics, sequela
Adverse effect of other specified systemic anti-infectives and antiparasitics, sequela
Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, sequela
Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, sequela
Adverse effect of other psychotropic drugs, sequela
Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, sequela
Adverse effect of antivaricose drugs, including sclerosing agents, sequela
Adverse effect of other agents primarily affecting gastrointestinal system, sequela
Adverse effect of other topical agents, sequela
Adverse effect of diagnostic agents, sequela